Connect coverage policy to the care that follows.
Apply the plan’s documented benefit and PBM rules, then present the prescribing clinicians, pharmacy arrangements and metabolic-care programs the plan already offers. Clinical eligibility and prescriptions remain clinician decisions.
of firms with 200 or more workers that offer health benefits covered GLP-1 agonists primarily for weight loss in their largest plan in 2026.
Limitation: Measures large-firm coverage policy. It says nothing about utilization, cost or clinical results.
Source: KFF, 2026 Employer Health Benefits Survey ↗Why it matters to self-funded plans
GLP-1 coverage is usually decided in plan design and PBM policy, while the care that follows happens elsewhere: with a prescriber, a pharmacy and sometimes a nutrition or lifestyle program. The plan rarely sees how those pieces connect.
Governance can help the plan apply its stated rules consistently, point members to resources it already pays for, and see whether each handoff was acknowledged.
What the plan may configure
Illustrative care destinations
The PPO network and the standard PBM process stay available.
What partner response and encounter evidence should return
What must be validated first
This page describes an illustrative governance application, not a deployed pathway. Deployment depends on plan-specific applicability, partner capacity, authority and validated workflows. See current product maturity →
Start with the plan’s agreements and available claims.
The Control Tower assessment establishes the plan’s baseline and helps determine which care priorities may warrant governance.